Tandem Diabetes Care Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report5 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+19.11%
vs ±17.0% implied · ×1.12
shaded = implied · ▲▼ = realized
Tandem Diabetes Care has 7 disclosed suppliers and 0 disclosed customers in SEC filings.
Tandem Diabetes Care Inc
19.10
SentenceAcquired IPR&D expenses were $75.2 million for the year ended December 31, 2025, which represented costs associated with the revised AMF purchase agreement (see Note 13, "Acquisitions").
TNDM 10-Kaccession 0001438133-26-000010
SentenceWe have received certification from BSI Group, a Notified Body to the International Standards Organization (ISO), of our quality system.
TNDM 10-Kaccession 0001438133-26-000010
SentenceFor example, we purchase all of our currently marketed infusion sets from a third-party supplier, Unomedical A/S, a subsidiary of the ConvaTec Group.
TNDM 10-Kaccession 0001438133-26-000010
SentenceFor example, we purchase all of our currently marketed infusion sets from a third-party supplier, Unomedical A/S, a subsidiary of the ConvaTec Group.
TNDM 10-Kaccession 0001438133-26-000010
—
Linked news
Expected move
Inputs8Q avg ±20.8%·×0.10·cheap
straddle ±14.3%
spot 19.11exp Nov 20ATM strike 19ATM straddle 3.23IV 89%